Artwork
iconShare
 
Manage episode 337211741 series 3380023
Content provided by Stephen Jenkins, MD, Austin Rupp, MD, Stephen Jenkins, MD, and Austin Rupp. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Stephen Jenkins, MD, Austin Rupp, MD, Stephen Jenkins, MD, and Austin Rupp or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Today we have special guest Dr. Valerie Vaughn to talk about her new paper in Open Forum Infectious Diseases about inappropriate treatment and testing for asymptomatic bacteriuria. Then we talk about the new ACTT-2 trial results of baricitinib plus remdesivir for COVID-19. We also review the BioNTech/Pfizer vaccine safety and efficacy results, a noninvasive respiratory protocol to reduce intubations in COVID-19, and iron deficiency in acute heart failure.
Testing and Treating Asymptomatic Bacteriuria Initiated in the ED
Baricitinib Plus Remdesivir for COVID-19 (ACTT-2 trial)
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Non-invasive respiratory protocol for COVID-19
Ferric Carboxymaltose for Acute HFrEF and Iron Deficiency
Music from https://filmmusic.io
"Sneaky Snitch" by Kevin MacLeod (https://incompetech.com)
License: CC BY (http://creativecommons.org/licenses/by/4.0/)

Music from Uppbeat (free for Creators!):

https://uppbeat.io/t/soundroll/dope

License code: NP8HLP5WKGKXFW2R

  continue reading

62 episodes